Review

Published on 06 Aug 2024

Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges

in Gastrointestinal and Hepatic Pharmacology

Ying Yang
Xiaojing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419384

908 views

Original Research

Published on 31 Jul 2024

The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis

in Gastrointestinal and Hepatic Pharmacology

Paolo Comeglio
Giulia Guarnieri
Sandra Filippi
Ilaria Cellai
Gabriele Acciai
Ian Holyer
Fredrik Zetterberg
Hakon Leffler
Barbro Kahl-Knutson
Erica Sarchielli

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430109

1,687 views

Original Research

Published on 31 Jul 2024

Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis

in Gastrointestinal and Hepatic Pharmacology

Miaomiao Yang
Xiongying Jiang
Huan Liu
Qingyu Zhang
Jing Li
Li Shao
Lei Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410767

965 views

Original Research

Published on 31 Jul 2024

Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD

in Gastrointestinal and Hepatic Pharmacology

Ang Huang
Cailun Zou
Zhe Dai
Ying Sun
Jing Wang
Shuhong Liu
Lin Han
Songhai Chen
Qingsheng Liang
Chunyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437479

873 views

Systematic Review

Published on 31 Jul 2024

Single and combined strategies for mesenchymal stem cell exosomes alleviate liver fibrosis: a systematic review and meta-analysis of preclinical animal models

in Gastrointestinal and Hepatic Pharmacology

Xiaolei Zhou
Yan Xu
Xuesong Wang
Wenming Lu
Xingkun Tang
Yu Jin
Junsong Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432683

1,194 views

Original Research

Published on 30 Jul 2024

A scientometrics analysis and visualization of refractory gastroesophageal reflux disease

in Gastrointestinal and Hepatic Pharmacology

Nan Zhang
Ming Han
Qin-Wei Zheng
Meng-Yuan Zhang
Wen-Lan Zhi
Jing-Jing Li
Lin-Xuan Cui
Jin-Li Tian
Yi Wang
Sheng-Quan Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393526

1,103 views

Systematic Review

Published on 29 Jul 2024

A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection

in Gastrointestinal and Hepatic Pharmacology

Lingbo Hu
Chao Yang
Yingli Qiao
Aidong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443551

909 views

Original Research

Published on 29 Jul 2024

Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response

in Gastrointestinal and Hepatic Pharmacology

Long Shu
Hangjie Fu
Aiwen Pi
Yuliang Feng
Hui Dong
Caijuan Si
Songtao Li
Feiye Zhu
Peifen Zheng
Qin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424219

1,252 views

Review

Published on 26 Jul 2024

Exploring the gut microbiota’s crucial role in acute pancreatitis and the novel therapeutic potential of derived extracellular vesicles

in Gastrointestinal and Hepatic Pharmacology

Yijie Li
Jie Li
Sen Li
Shumin Zhou
Jiahua Yang
Ke Xu
Yafeng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437894

1,199 views

Original Research

Published on 26 Jul 2024

Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

in Gastrointestinal and Hepatic Pharmacology

Yanni Li
Yaoyu Guo
Chong Geng
Shuailing Song
Wenjuan Yang
Xiao Li
Chunhui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1421577

1,134 views
1 citation

Review

Published on 22 Jul 2024

Efficacy and safety of peroxisome proliferator-activated receptor agonists for the treatment of primary biliary cholangitis: a meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Gang Tang
Jie Zhang
Linyu Zhang
Lingying Xia
Xiaojuan Tang
Rui Chen
Rongxing Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432814

1,301 views

Original Research

Published on 19 Jul 2024

Revealing the role of metformin in gastric intestinal metaplasia treatment

in Gastrointestinal and Hepatic Pharmacology

Ruoyu Hu
Xia Xue
Xiangdong Sun
Yang Mi
Huijuan Wen
Huayuan Xi
Fuhao Li
Pengyuan Zheng
Simeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1340309

1,951 views

Original Research

Published on 17 Jul 2024

Platycodon D reduces obesity and non-alcoholic fatty liver disease induced by a high-fat diet through inhibiting intestinal fat absorption

in Gastrointestinal and Hepatic Pharmacology

Xingkui Tang
Yi Yang
Wenxu Peng
Mengping Xu
Qitong Fan
Feng Li
Guorong Zou
Jianlin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412453

1,245 views

Review

Published on 16 Jul 2024

Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine

in Gastrointestinal and Hepatic Pharmacology

Shihao Zheng
Chengyuan Xue
Size Li
Xiaobin Zao
Xiaoke Li
Qiyao Liu
Xu Cao
Wei Wang
Wenying Qi
Hongbo Du

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381476

2,631 views

Original Research

Published on 11 Jul 2024

Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5

in Gastrointestinal and Hepatic Pharmacology

Zhaoyi Li
Wenjing Cao
Yuxuan Zhang
Shanglei Lai
Yingyan Ye
Jianfeng Bao
Ai Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423634

1,179 views

Systematic Review

Published on 11 Jul 2024

Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis

in Gastrointestinal and Hepatic Pharmacology

Naqash Alam
Linying Jia
Ao Cheng
Honghao Ren
Yu Fu
Xinhua Ding
Ihtisham Ul Haq
Enqi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390483

1,662 views
3 citations

Navigation group

Articles

Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges

The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis

Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis

Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD

Single and combined strategies for mesenchymal stem cell exosomes alleviate liver fibrosis: a systematic review and meta-analysis of preclinical animal models

A scientometrics analysis and visualization of refractory gastroesophageal reflux disease

A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection

Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response

Exploring the gut microbiota’s crucial role in acute pancreatitis and the novel therapeutic potential of derived extracellular vesicles

Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway

Efficacy and safety of peroxisome proliferator-activated receptor agonists for the treatment of primary biliary cholangitis: a meta-analysis of randomized controlled trials

Revealing the role of metformin in gastric intestinal metaplasia treatment

Platycodon D reduces obesity and non-alcoholic fatty liver disease induced by a high-fat diet through inhibiting intestinal fat absorption

Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine

Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5

Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis